Crestline Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,774
Closed -$694K 139
2024
Q4
$694K Buy
13,774
+4,615
+50% +$233K 0.02% 479
2024
Q3
$424K Buy
+9,159
New +$424K 0.02% 395